Proteomic study reveals a functional network of cancer markers in the G1-Stage of the breast cancer cell cycle

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Tenga, Milagros J ^a   Lazar, Iulia M ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Cancer markers; Cell cycle; Mass spectrometry; Proteomics

Indexed keywords

TUMOR MARKER; PROTEOME;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CELL CYCLE CHECKPOINT; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; DNA REPAIR; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MCF 7 CELL LINE; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; APOPTOSIS; BIOLOGY; BREAST TUMOR; CELL ADHESION; CELL CYCLE; CELL MOTION; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; GENETIC DATABASE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; G1 PHASE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84908118752     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-710     Document Type: Article

References (34)

1. Howard A, Pelc S. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 1953, 6(suppl):261-273.
2. Park M, Lee S. Cell cycle and cancer. J Biochem Mol Biol 2003, 36:60-65. 10.5483/BMBRep.2003.36.1.060, 12542976.
3. Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A 1974, 71:1286-1290. 10.1073/pnas.71.4.1286, 388211, 4524638.
4. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246:629-634. 10.1126/science.2683079, 2683079.
5. Ford HL, Pardee AB. Cancer and the cell cycle. J Cell Biochem 1999, 32-33(Suppl):166-172.
6. Weinberg RA. The Biology of Cancer 2007, New York: Garland Science, Taylor & Francis Group, LLC.
7. Tenga MJ, Lazar IM. A proteomic snapshot of breast cancer cell cycle: The G1/S Transition Point. Proteomics 2013, 13:48-60. 10.1002/pmic.201200188, 4123745, 23152136.
8. Sarvaiya HA, Yoon JH, Lazar IM. Proteome profile of the MCF-7 cancer cell line: a mass spectrometric evaluation. Rapid Commun Mass Spectrom 2006, 20:3039-3055. 10.1002/rcm.2677, 16986208.
9. Yang X, Lazar IM. MRM screening/biomarker discovery: a library of human cancer-specific peptides. BMC Cancer 2009, 9:96. 10.1186/1471-2407-9-96, 2670839, 19327145.
10. Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003, 31:3784-3788. 10.1093/nar/gkg563, 168970, 12824418.
11. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, Weinstein JN. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003, 4:R28. 10.1186/gb-2003-4-4-r28, 154579, 12702209.
12. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
13. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 3720094, 12734009.
14. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, Bork P, von Mering C. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009, 37:D412-D416. 10.1093/nar/gkn760, 2686466, 18940858.
15. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A, Lancet D. GeneCards Version 3: the human gene integrator. Database 2010, 2010. 1-16. Article ID baq020, doi:10.1093/database/baq020.
16. Hanahan D, Weinberg RA. The hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
17. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 2000, 28:27-30. 10.1093/nar/28.1.27, 102409, 10592173.
18. Hochegger H, Dejsuphong D, Sonoda E, Saberi A, Rajendra F, Kirk J, Hunt T, Takeda S. An essential role for Cdk1 in S phase control is revealed via chemical genetics in vertebrate cells. J Cell Biol 2007, 178:257-268. 10.1083/jcb.200702034, 2064445, 17635936.
19. Polanski M, Anderson NL. A list of candidate cancer biomarkers for targeted proteomics. Biomark Insights 2006, 1:1-48.
20. Diehl JA, Ponugoti B. Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibility. Genes Cancer 2010, 1:717-724. 10.1177/1947601910382902, 2991141,2991141, 21113395.
21. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007, 35:495-516. 10.1080/01926230701320337, 2117903, 17562483.
22. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010, 40:179-204. 10.1016/j.molcel.2010.09.019, 2988877, 20965415.
23. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation and cancer. Cell 2010, 140:883-899. 10.1016/j.cell.2010.01.025, 2866629, 20303878.
24. McSherry EA, Donatello S, Hopkins AM, McDonnell S. Molecular basis of invasion in breast cancer. Cell Mol Life Sci 2007, 64:3201-3218. 10.1007/s00018-007-7388-0, 17957337.
25. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996, 84:345-357. 10.1016/S0092-8674(00)81279-9, 8608588.
26. Varki A, Kannagi R, Toole BP. Glycosylation changes in cancer, chapter 44. Essentials of Glycobiology 2009, New York: Cold Spring Harbor Laboratory Press, Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, 2.
27. Braga V. The crossroads between cell-cell adhesion and motility. Nat Cell Biol 2000, 2(10):E182-E184. 10.1038/35036433, 11025678.
28. Futamura M, Nishimori H, Shiratsuchi T, Saji S, Nakamura Y, Tokino T. Molecular cloning, mapping and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1. J Hum Genet 1999, 44:52-56. 10.1007/s100380050107, 9929979.
29. Brown G, Hughes PJ, Michell RH. Cell differentiation and proliferation-simultaneous but independent?. Exp Cell Res 2003, 291:282-288. 10.1016/S0014-4827(03)00393-8, 14644151.
30. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it!. J Cell Physiol 2010, 222:42-49. 10.1002/jcp.21943, 2915440, 19798694.
31. Lemarie A, Grimm S. Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer. Oncogene 2011, 30:3985-4003. 10.1038/onc.2011.167, 21625217.
32. Brown NS, Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 2001, 3:323-327. 10.1186/bcr315, 138696, 11597322.
33. Liu R, Wang X, Aihara K, Chen L. Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers. Med Res Rev 2013, in press.
34. Csermely P, Ágoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005, 26:178-182. 10.1016/j.tips.2005.02.007, 15808341.